Round 1 Winners!
Proof of Usefulness Report

SiBioLEAD LLC

Analysis completed on 3/18/2026

+17.64
Proof of Usefulness Score
You're In Business

The project outlines a potentially useful suite of computational biology and drug discovery solutions. However, the submission is severely compromised by highly exaggerated and impossible traction claims ('most people have used my product') and poorly defined target audiences ('everyone'). Due to the lack of verifiable metrics and low response quality, the project receives significant penalties, reflecting minimal verifiable traction.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+15.0
Audience Reach Impact-2.0
Technical Innovation+7.5
Evidence Of Traction-6.25
Market Timing Relevance+7.0
Functional Completeness-0.5
Subtotal+20.75
Usefulness Multiplierx0.85
Final Score+18

Project Details

Project URL
Description
SiBioLead, offers virtual drug discovery and computational biology solutions, including (a) High-throughput Virtual Library Screening of combinatorial libraries, (b) Kinome-wide virtual screening (Virtual Kinase Profiling), (c) Microsecond scale molecular dynamic simulations, (d) Protein-protein interaction analysis, (e) Machine learning, and neural network for both academics and biotechnology/pharmaceutical companies. We have a dedicated team of trained bioinformatics experts, and cloud-based High-Performance GPU Computing support to perform client-based and personalized high-demand computational biology tasks.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline